Progression-free survival 1 year after treatment initiation of the last patient [clinicaltrials_resource:1dea676cedd46484732f5994f337f38a]
Defined as the time interval from date on treatment until the date of first progression, medulloblastoma-related death or date of last contact for patients who have not experienced an event. All eligible patients who receive any methotrexate will be included in the analysis.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Progression-free survival 1 year after treatment initiation of the last patient [clinicaltrials_resource:1dea676cedd46484732f5994f337f38a]
Defined as the time interval from date on treatment until the date of first progression, medulloblastoma-related death or date of last contact for patients who have not experienced an event. All eligible patients who receive any methotrexate will be included in the analysis.
Bio2RDF identifier
1dea676cedd46484732f5994f337f38a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1dea676cedd46484732f5994f337f38a
measure [clinicaltrials_vocabulary:measure]
Progression-free survival
time frame [clinicaltrials_vocabulary:time-frame]
1 year after treatment initiation of the last patient
description
Defined as the time interval f ...... l be included in the analysis.
identifier
clinicaltrials_resource:1dea676cedd46484732f5994f337f38a
title
Progression-free survival 1 year after treatment initiation of the last patient
@en
type
label
Progression-free survival 1 ye ...... a676cedd46484732f5994f337f38a]
@en